DLRHX Holdings Information

DLRHX is a mutual fund with a total of 108 individual holdings. The top holdings are UCB SA stock at 5.51%, Regeneron Pharmaceuticals at 5.22%, Pfizer at 4.50%, Gilead Sciences at 4.45%, and Chugai Pharmaceutical at 4.28%.

Total Holdings

108

Top 10 Percentage

43.39%

Asset Class

Equity

Fund Category

Health

Assets

664.98M

Forward PE Ratio

16.16

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	EBR: UCB	UCB SA	5.51%	130,137
2	REGN	Regeneron Pharmaceuticals, Inc.	5.22%	47,000
3	PFE	Pfizer Inc.	4.50%	1,145,000
4	GILD	Gilead Sciences, Inc.	4.45%	210,000
5	TYO: 4519	Chugai Pharmaceutical Co., Ltd.	4.28%	450,000
6	ABBV	AbbVie Inc.	4.12%	125,000
7	LON: AZN	AstraZeneca PLC	3.91%	131,243
8	LLY	Eli Lilly and Company	3.89%	26,000
9	MRK	Merck & Co., Inc.	3.78%	215,000
10	SWX: ROP	Roche Holding AG	3.73%	55,000
11	UNH	UnitedHealth Group Incorporated	2.92%	70,000
12	ELV	Elevance Health, Inc.	2.86%	63,000
13	BSX	Boston Scientific Corporation	2.73%	250,000
14	AMGN	Amgen Inc.	2.59%	47,000
15	VTRS	Viatris Inc.	2.48%	1,170,018
16	HALO	Halozyme Therapeutics, Inc.	2.17%	220,000
17	VRTX	Vertex Pharmaceuticals Incorporated	1.77%	25,000
18	ILMN	Illumina, Inc.	1.72%	90,000
19	EPA: SAN	Sanofi	1.66%	120,000
20	VKTX	Viking Therapeutics, Inc.	1.59%	330,100
21	ALNY	Alnylam Pharmaceuticals, Inc.	1.42%	30,000
22	ROIV	Roivant Sciences Ltd.	1.39%	338,181
23	FNMA	Federal National Mortgage Association Fannie Mae	1.33%	1,300,000
24	NBIX	Neurocrine Biosciences, Inc.	1.32%	70,000
25	COGT	Cogent Biosciences, Inc.	1.27%	230,000

Showing 25 of 108 holdings

Subscribe to see the full list

Activate Now

As of Feb 28, 2026